Insider Transactions in Q3 2021 at Poseida Therapeutics, Inc. (PSTX)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 20
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,000
-11.07%
|
$160,000
$8.0 P/Share
|
Sep 14
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,000
-9.97%
|
$160,000
$8.14 P/Share
|
Sep 13
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,281
+1.54%
|
$106,405
$5.16 P/Share
|
Sep 09
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.26%
|
$10,000
$1.32 P/Share
|
Sep 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
61,262
-0.86%
|
$490,096
$8.34 P/Share
|
Sep 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
51,149
-0.71%
|
$409,192
$8.46 P/Share
|
Aug 20
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-8.79%
|
$32,000
$8.79 P/Share
|
Aug 20
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+8.08%
|
$4,000
$1.32 P/Share
|
Aug 06
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
111,149
+14.52%
|
$1,000,341
$9.15 P/Share
|
Aug 03
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
19,936
-0.28%
|
$139,552
$7.99 P/Share
|
Aug 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
13,737
-0.19%
|
$109,896
$8.13 P/Share
|
Jul 28
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+32.53%
|
$20,000
$1.32 P/Share
|
Jul 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
27,542
-0.19%
|
$247,878
$9.28 P/Share
|
Jul 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,563
-0.28%
|
$185,067
$9.77 P/Share
|